The impact of socioeconomic level on influenza vaccination among Italian adults and elderly: A cross-sectional study

Preventive Medicine

Volumn 45, Issue 5, 2007, Pages 373-379

  Damiani, G ^a   Federico, B ^b   Visca, M ^a   Agostini, F ^a   Ricciardi, W ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Faculty of Health and Sport Sciences   (Italy)

Author keywords

Adults and elderly; Influenza vaccination; Socioeconomic inequalities

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SERVICE; HEALTH STATUS; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INTERVIEW; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OCCUPATION; PRIORITY JOURNAL; RISK ASSESSMENT; SELF REPORT; SMOKING; SOCIOECONOMICS; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEYS; HUMANS; INFLUENZA VACCINES; ITALY; MALE; MASS IMMUNIZATION; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; SOCIAL CLASS;

EID: 35648949468     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2007.07.007     Document Type: Article

References (57)

1. Ahmed A.H., Nicholson K.G., and Nguyen-Van-Tam J.S. Reduction in Mortality associated with influenza vaccine during 1989-90 epidemic. Lancet 346 8975 (1995) 591-595
2. Ambrosch F., and Fedson D.S. Influenza vaccination in 29 countries: an update to 1997. Pharmacoeconomics 16 Suppl.1 (1999) 47-54
3. Andrew M.K., Mc Neil S., Merry H., and Rockwood K. Rates of influenza vaccination in older adults and factors associated with vaccine use: a secondary analysis of the Canadian Study of Health and Aging. BMC Public Health 4 36 (2004) 10.1186/1471-2458-4-36
4. Armstrong K., Berlin M., Schwartz J.S., Propert K., and Ubel P.A. Barriers to influenza immunization in a low income urban population. Am. J. Prev. Med. 20 1 (2001) 21-25
5. Bonito A.J., Lenfestey N.F., Eicheldinger C., Iannacchione V.G., and Campbell L. Disparities in immunizations among elderly Medicare beneficiaries, 2000 to 2002. Am. J. Prev. Med. 27 2 (2004) 153-160
6. Bridges C.B., Thompson W.W., Meltzer M.I., et al. Effectiveness and cost benefit of influenza vaccination of healthy working adults randomized controlled trial. JAMA 284 (2000) 1655-1663
7. C.D.C.-Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR. Morb. Mortal. Wkly. Rep., CDC Surveill. Summ. 49 RR-3 (2000) 1-38
8. C.D.C.-Centers for Disease Control and Prevention. Influenza vaccination levels among persons aged ≥ 65 years and among persons aged 18-64 years with high-risk conditions - United States, 2003. MMWR Morb. Mortal Wkly. Rep. 54 41 (2005) 1045-1049
9. Cobalti A., and Schizzerotto A. La mobilità sociale in Italia (1994), Mulino, Bologna, Il
10. Demicheli V. Mass influenza vaccination in Ontario: is it worthwhile?. CMAJ 164 1 (2001) 38-41
11. Egede L.E., and Zheng D. Racial/Ethnic differences in influenza vaccination coverage in high-risk adults research and practice. Am. J. Public Health 93 12 (2003) 2074-2077
12. European Observatory on Health Systems and Policies: HiT country profiles http://www.euro.who.int/observatory/Hits/TopPage-last access: May, 2007.
13. European Influenza Surveillance Scheme: http://www.eiss.org/html/vaccination.html - last access: July, 2006.
14. Fiscella K., Franks P., Gold M.R., and Clancy C.M. Inequality in quality-addressing socioeconomic, racial, and ethnic disparities in health care. (Reprinted). JAMA 283 19 (2000) 2579-2585
15. Gasparini R., Lucioni C., Laia P., et al. Cost-benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria. Vaccine 20 (2002) B50-B54
16. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., and Levandowsky L.A. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann. Intern. Med. 123 7 (1995) 518-527
17. Hak E., Buskens E., van Essen G.A., et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions. The Prisma Study. Arch. Intern. Med. 1165 (2005) 274-280
18. Hammond G.W. Strategy for the control of influenza infections. Can J. CME (2002) 141-147
19. Harper S.A., Fukada K., Uyeki T.M., Cox N.J., and Bridges C.B. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza. Recommendations and reports. CDC-MMWR Morb. Mortal Wkly. Rep. 53 RR06 (2004) 1-40
20. Hebert P.L., Frick K.D., Kane R.L., and Macbean A.M. Racial disparities the causes of racial and ethic differences in influenza vaccination rates among elderly Medicare beneficiaries. Health Serv. Res. 40 2 (2005) 517-538
21. Hutchison B.G. Measurement of influenza vaccination status of the elderly by mailed questionnaire: response rate, validity and cost. Can. J. Public Health 80 4 (1989) 271-275
22. Jefferson T., Rivetti D., Rudin M., Di Pietrantoni C., and Demicheli V. Efficacy and effectiveness on influenza vaccine in elderly people: a sistematic review. Lancet 366 (2005) 1165-1174
23. Jones T.F., Ingram L.A., Craig A.S., and Schaffner W. Determinants of influenza vaccination, 2003-2004: Shortages, Fallacies and Disparities. Clin. Infect. Dis. 39 (2004) 1824-1828
24. Joseph C., and Goddard N.L. Influenza vaccine uptake in the elderly: results from a rapid assessment of the effectiveness of new government policy in England for the winters 2000/2001 and 2001/2002. Vaccine 21 (2003) 1137-1148
25. Kroneman M., Paget W.J., and van Essen G.A. Influenza vaccination in Europe: an inventory of strategies to reach target populations and optimize vaccination uptake. Eurosorvellaince 8 6 (2003) 130-138
26. Landi F., Onder G., Carpenter I., Garms-Homolova V., and Bernabei R. Prevalence and predictors of influenza vaccination among frail, community-living elderly patients: an international observational study. Vaccine 23 (2005) 3896-3901
27. Lorant V., Boland B., Humblet P., and Deliège D. Equity in prevention and Health care. J. Epidemiol. Community Health 56 (2002) 510-516
28. Mac Donald R., Baken L., and Nickol K.L. Validation of self-reported influenza and pneumococcal vaccination status in elderly outpatients. Am. J. Prev. Med. 16 (1999) 173-177
29. Mangtani P., Breeze E., Kovats S., Ng E.S., Roberts J.A., and Fletcher A. Inequalities in influenza vaccine uptake among people aged over 74 years in Britain. Prev. Med. 41 2 (2005) 545-553
30. Marin M.G., Johanson W.G., and Salas-Lopez D. Influenza vaccination among minority populations in the United States. Prev. Med. 34 (2002) 235-241
31. Ministero della Salute Direzione Generale della Prevenzione Sanitaria - Ufficio V Malattie Infettive e profilassi internazionale. Prevenzione e controllo dell'influenza: raccomandazioni per la stagione 2005-2006. (Prot. DGPREV/V/18572/P/l.4.c.a.9.2005) (2005). http://www.ministerosalute.it/imgs/C_17_normativa_566_allegato.pdf http://www.ministerosalute.it/imgs/C_17_normativa_566_allegato.pdf-last access: July, 2006
32. Ministero della Salute-Dipartimento malattie infettive:coperture vaccinali http://www.ministerosalute.it/promozione/malattie/dati_statistici.jsp?la bel=cop-last access: July, 2006
33. Muller D., and Szucs T.D. Coverage rates of influenza vaccine in Italy during the 2002/3 and 2003/4 seasons: a cross-sectional study. Ann. Ig. (Roma) 17 4 (2005) 351-363
34. Nicoleau C., Nicoleau A., Balzora J.D., Oboh A., Siddiqui N., and Rosenberg C. Elderly African-Americans and the influenza vaccine: the impact of the primary care physician. J. Am. Med. Dir. Assoc. 2 (2001) 56-59
35. Nichol K.L. The efficacy, effectiveness and cost effectiveness of inactivated influenza virus vaccines. Vaccine 21 (2003) 1769-1775
36. Nichol K.L., Margolis K.L., Wuorenma J., and Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N. Engl. J. Med. 331 (1994) 778-784
37. Nowalk M.P., Zimmerman R.K., Tabbarah M., Raymund M., and Jewell I.K. Determinants of adult vaccination at inner-city health centers: a descriptive study. BMC Fam. Pract. 7 2 (2006) 10.1186/1471-2296-7-2
38. Ompad D.C., Galea S., and Vlahov D. Distribution of influenza vaccine to high-risk groups. Epidemiol. Rev. 28 (2006) 54-70
39. Peterson R.L., Saag K., Wallace R.B., and Doebbling B.N. Influenza and pneumococcal vaccine receipt in older persons with chronic disease: a population-based study. Med. Care 37 (1999) 502-509
40. Piano Nazionale Vaccini (1999-2000) http://www.ministerosalute.it/imgs/C_17_normativa_526_ulterioriallegati_ ulterioreallegato_0_alleg.pdf-last access: July, 2006.
41. Pregliasco F., Sodano L., Mensi C., et al. Influenza vaccination among the elderly in Italy. Bull. World Health Organ 77 (1999) 127-131
42. Rangel M.C., Shoenbach V.J., Weigle K.A., Hogan V.K., Strauss R.P., and Bangdiwala S.I. Racial and ethnic disparities in influenza vaccination among elderly adults. J. Gen. Intern. Med. 20 (2005) 426-431
43. Sambamoorthi U., and Findley P.A. Who are the elderly who never receive influenza immunization?. Prev. Med. 40 4 (2005) 469-478
44. Sarria-Santamera A., and Timoner J. Influenza vaccination in old adults in Spain. Eur. J. Public Health 13 (2003) 133-137
45. Schwartz K.L., Neale A.V., Northrup J., et al. Racial similarities in response to standardized offer of influenza vaccination. A MetroNet Study. J. Gen. Intern. Med. 21 (2006) 346-351
46. Schneider E.C., Cleary P.D., Zaslavsky A.M., and Epstein A.M. Racial disparity in influenza vaccination: does managed care narrow the gap between African Americans and whites?. JAMA 286 12 (2001) 1455-1460
47. Study group. The macroepidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine 23 (2005) 5133-5143
48. Szucs T., and Muller D. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons. Vaccine 23 43 (2005) 5055-5063
49. Tabbarah M., Zimmerman R.K., Nowalk M.P., et al. What predict influenza status in older Americans over several year. J. Am. Geriatr. Soc. 53 8 (2005) 1354-1359
50. Thompson W.W., Shay D.K., Weintraub E., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003) 179-186
51. Van Doorslaer E., Masseria C., Koolman X., and for the Health Equity Research Group. Inequalities in access to medical care by income in developed countries. CMAJ 174 2 (2006) 177-183
52. Van Essen G.A., Palache A.M., Forleo E., and Fedson D.S. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 21 (2003) 1780-1785
53. V.D.A., net-Banca Dati Sanitaria Farmaceutica: Vaccino influenzale inattivato: http://www.giofil.it/offline/PSUAUETT.HTM-last access: May, 2007.
54. World Health Organization. Influenza vaccines: recommendations for the use of inactivated influenza vaccine and other preventive measures. Wkly. Epidemiol. Rec. 75 (2000) 281-288
55. World Health Organization. Influenza vaccines. Wkly. Epidemiol. Rec. 80 (2005) 277-288
56. Xakellis G.C. Predictor of influenza Immunization in persons over age 65. J. Am. Board Fam. Pract. 18 5 (2005) 426-433
57. Zimmerman R.K. Lowering the age for routine influenza vaccination to 50 years: AAFP leads the nation in influenza vaccine policy. Am. Fam. Phys. 60 7 (1999) 2061-2070